🧪 Define Bioavailability (F)
Bioavailability (F) is one of the most critical pharmacokinetic parameters used to describe a drug’s performance in vivo (within a living organism). For pharmacy students and professionals, understanding F is essential for designing effective dosing regimens and ensuring therapeutic success. It quantifies how much of an administered drug actually reaches the site of action.
Introduction to Bioavailability
Bioavailability is defined as the fraction of an administered dose of unchanged drug that reaches the systemic circulation and thus becomes available to produce a pharmacological effect.
When a drug is given intravenously (IV), it is assumed that 100% of the dose enters the bloodstream, so the bioavailability is 1 ($F=1$). However, when a drug is administered by any other route (oral, rectal, transdermal, etc.), the bioavailability is generally less than 100%.
What Influences Bioavailability (F)?
For a drug administered orally, its journey to the systemic circulation is complex and involves overcoming several barriers, which ultimately reduces its bioavailability.
1. Absorption from the GI Tract
The drug must first dissolve and then be absorbed through the gastrointestinal (GI) tract walls. Factors influencing this include:
Drug Solubility and Dissolution Rate: Poorly soluble drugs have low absorption.
Permeability: The ability of the drug to cross the biological membranes.
GI Motility and Transit Time: Fast transit may not allow enough time for absorption.
2. First-Pass Metabolism (Pre-systemic Elimination)
This is the most significant factor reducing oral bioavailability.
Hepatic Metabolism: After absorption from the intestine, the drug travels via the portal vein directly to the liver. The liver enzymes (e.g., Cytochrome P450) metabolize a portion of the drug before it reaches the general systemic circulation.
Intestinal Metabolism: Enzymes in the GI wall can also metabolize the drug before it even reaches the portal circulation.
The higher the first-pass effect, the lower the oral bioavailability.
Calculating Bioavailability (F)
Bioavailability is calculated by comparing the concentration of the drug in the systemic circulation over time after a non-intravenous dose versus an intravenous dose.
The Area Under the Curve (AUC)
The concentration of the drug in the blood plasma over time is graphically represented by the Area Under the Curve (AUC). The AUC reflects the total drug exposure achieved systemically.
Where:
$(AUC)_{non-IV}$: Area under the curve after oral or other non-IV administration.
$(AUC)_{IV}$: Area under the curve after IV administration (representing 100% bioavailability).
$Dose_{non-IV}$ and $Dose_{IV}$: The total doses administered.
Note: For a single dose comparison where the doses are equal, the formula simplifies to the ratio of the AUCs.
Importance of Bioavailability in B. Pharmacy
Understanding F is not just academic; it dictates clinical practice and regulatory approval:
Dose Determination: A drug with low oral bioavailability (e.g., $F=0.10$ or 10%) requires a much higher oral dose than its IV dose to achieve the same therapeutic effect.
Example: If a drug's therapeutic IV dose is 10 mg, and its oral F is 0.5 (50%), the required oral dose would be $\frac{10 \text{ mg}}{0.5} = 20 \text{ mg}$.
Route of Administration: Drugs with extremely low oral F (e.g., certain biologics like insulin) cannot be given orally and must be administered by injection.
Bioequivalence: Regulatory bodies require generic versions of a drug to demonstrate bioequivalence—meaning they must have the same rate ($C_{max}$ and $T_{max}$) and extent ($AUC$) of absorption as the innovator product. This ensures that the generic drug will be therapeutically equivalent.
Drug Formulation: Pharmacists and pharmaceutical scientists utilize F to design formulations (tablets, capsules, suspensions) that enhance a drug's solubility and permeability, thus improving its overall absorption and bioavailability.
Conclusion
Bioavailability is the gold standard metric for assessing the efficiency of drug delivery to the systemic circulation. It serves as the foundation for rational drug design, accurate dosage calculation, and the critical regulatory process of approving therapeutically interchangeable generic medicines. A solid understanding of F is indispensable for ensuring patient safety and treatment efficacy.
){kind=link}